| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $425,039 | 15 | 56 |
Sells | $127,013 | 12 | 44 |
| Stuka Paul | director | 11 | $191,002 | 0 | $0 | $191,002 |
| ROUBIN GARY S | director | 1 | $106,200 | 0 | $0 | $106,200 |
| Ward Scott R. | director | 2 | $102,638 | 0 | $0 | $102,638 |
| Slosman Marvin | CEO and President | 1 | $25,200 | 0 | $0 | $25,200 |
| Gleason Shane Thomas | Chief Commercial Officer | 0 | $0 | 12 | $127,013 | $-127,013 |
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid …
Over the last 12 months, insiders at InspireMD, Inc. have bought $425,039 and sold $127,013 worth of InspireMD, Inc. stock.
On average, over the past 5 years, insiders at InspireMD, Inc. have bought $393,145 and sold $144,462 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Stuka Paul (director) — $191,002. ROUBIN GARY S (director) — $106,200. Ward Scott R. (director) — $102,638.
The last purchase of 20,000 shares for transaction amount of $17,500 was made by Stuka Paul (director) on 2026‑05‑27.
| 2026-05-27 | Stuka Paul | director | 20,000 0.0425% | $0.88 | $17,500 | -18.42% | ||
| 2026-05-19 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 22,778 0.0491% | $1.01 | $23,006 | -28.05% | |
| 2026-05-14 | Stuka Paul | director | 5,000 0.0108% | $1.15 | $5,750 | -36.84% | ||
| 2026-05-13 | Stuka Paul | director | 10,000 0.0211% | $1.16 | $11,575 | -38.46% | ||
| 2026-05-12 | Slosman Marvin | CEO and President | 21,000 0.0448% | $1.20 | $25,200 | -40.00% | ||
| 2026-05-11 | Stuka Paul | director | 10,000 0.0203% | $1.19 | $11,900 | -42.40% | ||
| 2026-05-08 | Stuka Paul | director | 65,626 0.1412% | $1.16 | $76,126 | -37.39% | ||
| 2026-05-07 | ROUBIN GARY S | director | 90,000 0.1952% | $1.18 | $106,200 | -37.93% | ||
| 2026-05-07 | Stuka Paul | director | 6,378 0.0135% | $1.15 | $7,335 | -37.93% | ||
| 2026-05-07 | Ward Scott R. | director | 73,255 0.1549% | $1.15 | $84,243 | -37.93% | ||
| 2026-05-06 | Stuka Paul | director | 1,517 0.0031% | $1.12 | $1,699 | -37.93% | ||
| 2026-05-06 | Ward Scott R. | director | 15,995 0.0338% | $1.15 | $18,394 | -37.93% | ||
| 2026-02-02 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 2,000 0.0046% | $1.60 | $3,208 | -46.02% | |
| 2026-02-02 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 2,941 0.0068% | $1.59 | $4,676 | -46.02% | |
| 2026-01-30 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 2,900 0.0071% | $1.63 | $4,730 | -44.30% | |
| 2026-01-29 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 5,000 0.0121% | $1.65 | $8,250 | -45.63% | |
| 2026-01-28 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 12,395 0.0293% | $1.65 | $20,464 | -46.57% | |
| 2026-01-27 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 4,781 0.0114% | $1.66 | $7,956 | -46.35% | |
| 2026-01-22 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 8,411 0.0183% | $1.57 | $13,239 | -47.95% | |
| 2026-01-21 | Sale | Gleason Shane Thomas | Chief Commercial Officer | 17,593 0.0427% | $1.62 | $28,553 | -45.04% |
| Slosman Marvin | CEO and President | 3556658 7.6505% | $2.34M | 4 | 0 | <0.0001% |
| ROUBIN GARY S | director | 834478 1.795% | $549,003.08 | 10 | 0 | <0.0001% |
| Stuka Paul | director | 667871 1.4366% | $439,392.33 | 23 | 1 | <0.0001% |
| Ward Scott R. | director | 237096 0.51% | $155,985.46 | 2 | 0 | |
| MILINAZZO ALAN | President and CEO | 1423436 3.0619% | $936,478.54 | 6 | 0 | |
| BARER SOL J | director | 1141690 2.4558% | $751,117.85 | 16 | 0 | |
| Kester Thomas J | director | 420758 0.9051% | $276,816.69 | 4 | 1 | <0.0001% |
| Barry James J | Executive VP and COO | 169231 0.364% | $111,337.07 | 1 | 0 | |
| Olson Eric L. | VP of Global Sales Operations | 147163 0.3166% | $96,818.54 | 2 | 0 | |
| BERMAN MICHAEL | director | 122497 0.2635% | $80,590.78 | 3 | 0 | +4.91% |
| LOUGHLIN JAMES J | director | 51501 0.1108% | $33,882.51 | 2 | 0 | |
| Rogers Campbell | director | 8475 0.0182% | $5,575.70 | 1 | 0 |
| Increased Positions | 19 | +39.58% | 2M | +9.83% |
| Decreased Positions | 14 | -29.17% | 2M | -7.89% |
| New Positions | 12 | New | 216,141 | New |
| Sold Out Positions | 8 | Sold Out | 1M | Sold Out |
| Total Postitions | 53 | +10.42% | 23M | +1.93% |
| Rosalind Advisors, Inc. | $7,265.00 | 9.3% | 3.91M | +2M | +70.62% | 2025-09-30 |
| Nantahala Capital Management, Llc | $6,280.00 | 8.04% | 3.38M | +1M | +45.66% | 2025-09-30 |
| Aberdeen Group Plc | $4,615.00 | 5.91% | 2.48M | +2M | New | 2025-09-30 |
| Parkman Healthcare Partners Llc | $4,540.00 | 5.81% | 2.44M | +1M | +97.57% | 2025-09-30 |
| Velan Capital Investment Management Lp | $3,987.00 | 5.1% | 2.14M | +1M | +137.13% | 2025-09-30 |
| Orbimed Advisors Llc | $3,968.00 | 5.08% | 2.13M | 0 | 0% | 2025-09-30 |
| Marshall Wace, Llp | $3,460.00 | 4.43% | 1.86M | 0 | 0% | 2025-09-30 |
| Soleus Capital Management, L.P. | $2,736.00 | 3.5% | 1.47M | -415,273 | -22.02% | 2025-09-30 |
| Ghisallo Capital Management Llc | $1,714.00 | 2.19% | 921,587 | +921,587 | New | 2025-09-30 |
| Pura Vida Investments, Llc | $838.00 | 1.07% | 450,517 | 0 | 0% | 2025-09-30 |